{
  "data": {
    "broad_sector": "PHARMA",
    "niche_industry": "Generic and Specialty Pharmaceuticals",
    "sector_kpis": {
      "kpi_1": "R&D Spend: 8.0% of Revenue",
      "kpi_2": "US Sales Mix: 36%",
      "kpi_3": "EBITDA Margin: 24.7%"
    },
    "moat_rating": "Narrow",
    "competitive_position": "CHALLENGER"
  },
  "_cached_at": "2025-12-31T13:09:35.025115",
  "_symbol": "LUPIN"
}